UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

Journal of clinical oncology, 2010-02, Vol.28 (6), p.1061-1068

2010

Volltextzugriff (PDF)

Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma

Clinical cancer research, 2010-03, Vol.16 (5), p.1662-1672

2010

Volltextzugriff (PDF)

Building better chimeric antigen receptors for adoptive T cell therapy

Current gene therapy, 2010-04, Vol.10 (2), p.77-90

2010

Volltextzugriff (PDF)

Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes

Frontiers in immunology, 2023, Vol.14, p.1256491-1256491

2023

Volltextzugriff (PDF)

T Cell–Based Immunotherapy of Metastatic Renal Cell Carcinoma: Modest Success and Future Perspective

Clinical cancer research, 2009-11, Vol.15 (21), p.6503-6510

2009

Volltextzugriff (PDF)

CAR–T cells and solid tumors: tuning T cells to challenge an inveterate foe

Trends in molecular medicine, 2012-07, Vol.18 (7), p.377-384

2012

Volltextzugriff (PDF)

Vaccination of Colorectal Cancer Patients with Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax) Induces Immune Responses which Correlate with Disease Control: A Phase I/II Trial

Clinical cancer research, 2006-06, Vol.12 (11), p.3416-3424

2006

Volltextzugriff (PDF)

Transgenic T-cell receptor immunotherapy for cancer: building on clinical success

Therapeutic Advances in Vaccines and Immunotherapy, 2020, Vol.8, p.251513552093350

2020

Volltextzugriff (PDF)

A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update

European journal of cancer (1990), 2013-04, Vol.49 (6), p.1287-1296

2013

Volltextzugriff (PDF)

The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity

Cancer Immunology, Immunotherapy, 2017-11, Vol.66 (11), p.1425-1436

2017

Volltextzugriff (PDF)

CAR T cells: driving the road from the laboratory to the clinic

Immunological reviews, 2014-01, Vol.257 (1), p.91-106

2014

Volltextzugriff (PDF)

Immunohistochemical assessment of NY-ESO-1 expression in esophageal adenocarcinoma resection specimens

World journal of gastroenterology : WJG, 2014-04, Vol.20 (14), p.4011-4016

2014

Volltextzugriff (PDF)

Overcoming the toxicity hurdles of genetically targeted T cells

Cancer Immunology, Immunotherapy, 2015-01, Vol.64 (1), p.123-130

2015

Volltextzugriff (PDF)

Eotaxin-2 and Colorectal Cancer: A Potential Target for Immune Therapy

Clinical cancer research, 2007-10, Vol.13 (19), p.5719-5728

2007

Volltextzugriff (PDF)

Making Antibodies by Phage Display Technology

Annual review of immunology, 1994-01, Vol.12 (1), p.433-455

1994

Volltextzugriff (PDF)

Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma

Journal of clinical oncology, 2016-05, Vol.34 (14), p.1660-1668

2016

Volltextzugriff (PDF)

Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

Journal of clinical oncology, 2023-04, Vol.41 (11), p.1957-1964

2023

Volltextzugriff (PDF)

Massively parallel interrogation and mining of natively paired human TCRαβ repertoires

Nature biotechnology, 2020-05, Vol.38 (5), p.609-619

2020

Volltextzugriff (PDF)

Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

Clinical cancer research, 2010-11, Vol.16 (22), p.5539-5547

2010

Volltextzugriff (PDF)

Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells

Cancer Immunology, Immunotherapy, 2018-10, Vol.67 (10), p.1519-1531

2018

Volltextzugriff (PDF)

Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma

Clinical cancer research, 2021-06, Vol.27 (12), p.3317-3328

2021

Volltextzugriff (PDF)

Comparison of major adverse event rates after elective endovascular aneurysm repair in New England using a novel measure of complication severity

Journal of vascular surgery, 2019-07, Vol.70 (1), p.74-79

2019

Volltextzugriff (PDF)

Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial

JAMA oncology, 2017-07, Vol.3 (7), p.913

2017

Volltextzugriff (PDF)

A Randomized Phase II/III Study of Naptumomab Estafenatox + IFNα versus IFNα in Renal Cell Carcinoma: Final Analysis with Baseline Biomarker Subgroup and Trend Analysis

Clinical cancer research, 2016-07, Vol.22 (13), p.3172-3181

2016

Volltextzugriff (PDF)

1 – 25 von 964

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(864)
Mit Volltextzugriff
(777)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma

Building better chimeric antigen receptors for adoptive T cell therapy

Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes

T Cell–Based Immunotherapy of Metastatic Renal Cell Carcinoma: Modest Success and Future Perspective

CAR–T cells and solid tumors: tuning T cells to challenge an inveterate foe

Vaccination of Colorectal Cancer Patients with Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax) Induces Immune Responses which Correlate with Disease Control: A Phase I/II Trial

Transgenic T-cell receptor immunotherapy for cancer: building on clinical success

A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update

The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity

CAR T cells: driving the road from the laboratory to the clinic

Immunohistochemical assessment of NY-ESO-1 expression in esophageal adenocarcinoma resection specimens

Overcoming the toxicity hurdles of genetically targeted T cells

Eotaxin-2 and Colorectal Cancer: A Potential Target for Immune Therapy

Making Antibodies by Phage Display Technology

Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma

Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

Massively parallel interrogation and mining of natively paired human TCRαβ repertoires

Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells

Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma

Comparison of major adverse event rates after elective endovascular aneurysm repair in New England using a novel measure of complication severity

Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial

A Randomized Phase II/III Study of Naptumomab Estafenatox + IFNα versus IFNα in Renal Cell Carcinoma: Final Analysis with Baseline Biomarker Subgroup and Trend Analysis

Suchergebnisse filtern